PALO ALTO, Calif., Nov. 5, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) is scheduled to present at Lazard Capital Markets 9th Annual Healthcare Conference at 1:30 p.m. ET on Tuesday, November 13, at the Pierre Hotel in New York City.
Participating executives will be Dow Wilson, CEO, and Spencer Sias, vice president of investor relations and corporate communications. The presentation will focus on the company's growth opportunities in radiation oncology, X-ray imaging, proton therapy and security and inspection.
For automatic "e-mail alerts" regarding Varian news, events, and new investor materials on the website, investors can subscribe on the company website:
http://varian.investorroom.com/index.php?s=58. For additional information, contact investor relations at 1 650 424-5834.
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 6,100 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com.
FOR INFORMATION CONTACT:
Elisha Finney (650) 424-6803
Spencer Sias (650) 424-5782
SOURCE Varian Medical Systems